# Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation

> **NCT04700826** · PHASE4 · RECRUITING · sponsor: **University of Birmingham** · enrollment: 3000 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Direct Oral Anticoagulants

## Key facts

- **NCT ID:** NCT04700826
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2027-12
- **Final completion:** 2031-01
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04700826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04700826, "Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04700826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*